Supplementary Figure 4 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models
<p>Supplementary Figure 4: Correlation of PID count</p>
Gardado en:
| Autor Principal: | Shigehiro Yagishita (15088446) (author) |
|---|---|
| Outros autores: | Sho Sato (15352614) (author), Daisuke Shintani (15352611) (author), Tadaaki Nishikawa (15033960) (author), Aiko Ogasawara (22547757) (author), Masanori Yasuda (15352623) (author), Hironori Ishii (22547760) (author), Keiji Furuuchi (20667857) (author), Toshimitsu Uenaka (20667860) (author), Hiroshi Yoshida (15044363) (author), Kosei Hasegawa (15352632) (author), Akinobu Hamada (15352635) (author) |
| Publicado: |
2025
|
| Subjects: | |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Supplementary Figure 1 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models
por: Shigehiro Yagishita (15088446)
Publicado: (2025) -
Supplementary Figure 2 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models
por: Shigehiro Yagishita (15088446)
Publicado: (2025) -
Supplementary Figure 3 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models
por: Shigehiro Yagishita (15088446)
Publicado: (2025) -
Supplementary Data1 from Genomic Profiling in Patients with Endometrial Cancer by Deep Sequencing of Vaginal Swabs and Plasma
por: Namsoo Kim (21718000)
Publicado: (2025) -
Supplementary Table S4 from Evolution and Co-occurrence of PI3K Pathway Gene Mutations in Endometrial Carcinoma Molecular Subtypes at the Single-Cell Level
por: Arnaud Da Cruz Paula (17316230)
Publicado: (2025)